Sir: Anaphylaxis is a recognised reaction to Parentrovite administration.
The most recent data from the CSM show that up to August 1994, there have been 134 reports describing 251 reactions to intravenous Parentrovite, three of which were fatal (1 from cardiac arrest, 2 from anaphylactic shock). During the same period however, there have been 22 reports describing 36 reactions (1 fatality from 'aggravation of depression') to intramuscular Parentrovite (CSM, personal communication).
It seems from the CSM that parenteral administration should only be considered when this route was essential (Committee on Safety of Medicines, 1989) 
Balancing dependency and independence for the mentally ill
Sir: Doyle and Craig (Psychiatric Bulletin, 1995, 4, 223-225) give a realistic but encoura ging account of the development of a commu nity mental health team for the severely mentally ill. However, I had a feeling of heartsink when I read of the ethos of normal isation and development of independent living skills. If this was all, it seems rather restrictive and unlikely to meet many of the needs of the target group. What about contain ment, making up for deficits with care or even curing? Has the pendulum swung so far in psychiatry that we are afraid to advertise the fact that our patients are not necessarily on a programme, towards normality, but have special needs that may have always to be met by others, including psychiatric services? Balancing dependency needs with the need for independence is perhaps a task for all considered relationships and a statement of service aims that emphasises the latter at the expense of the former is unlikely to guide or inspire service providers. Research Fellow, Community Intervention Project, [144] [145] [146] [147] [148] [149] [150] Willesden. London NW10 2PT 
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